Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BAMM
BooksAMillion
$0.00
$1.59
$3.39
N/AN/A18,196 shsN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$8.50
-0.1%
C$8.12
C$3.11
C$9.98
C$203.92M0.9740,007 shs19,724 shs
Colossus Minerals Inc. stock logo
CSI
Colossus Minerals
C$0.00
C$0.01
C$3.40
N/AN/A158,798 shsN/A
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
$0.57
+7.6%
$0.48
$0.19
$1.43
$7.59M1.03557,289 shs113,085 shs
1933 Industries Inc. stock logo
TGIFF
1933 Industries
$0.01
$0.01
$0.01
$0.02
N/AN/A74,558 shs115,000 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
-0.12%-3.35%-10.53%+47.83%+152.23%
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
+7.15%-2.85%+24.41%+72.75%-15.39%
1933 Industries Inc. stock logo
TGIFF
1933 Industries
-9.60%-24.67%-13.08%+32.94%-20.98%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BAMM
BooksAMillion
N/AN/AN/AN/AN/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A
Colossus Minerals Inc. stock logo
CSI
Colossus Minerals
N/AN/AN/AN/AN/AN/AN/AN/A
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
N/AN/AN/AN/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BAMM
BooksAMillion
N/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
3.00
BuyC$8.00-5.88% Downside
Colossus Minerals Inc. stock logo
CSI
Colossus Minerals
N/AN/AN/AN/A
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
N/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/A

Current Analyst Ratings

Latest CPH, CSI, IMCC, TGIFF, and BAMM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
2/14/2024
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSpeculative Buy ➝ BuyC$4.75 ➝ C$8.00
(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BAMM
BooksAMillion
N/AN/AN/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$21.16M9.64C$2.41 per share3.53C$3.36 per share2.53
Colossus Minerals Inc. stock logo
CSI
Colossus Minerals
N/AN/AN/AN/AN/AN/A
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
$36.15M0.21N/AN/A$0.76 per share0.75
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BAMM
BooksAMillion
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$20.38MC$1.097.80N/A96.32%28.19%8.06%5/9/2024 (Estimated)
Colossus Minerals Inc. stock logo
CSI
Colossus Minerals
N/AN/A0.00N/AN/AN/AN/AN/AN/A
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
-$7.04M-$0.47N/AN/A-16.42%-44.25%-16.48%5/20/2024 (Estimated)
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/A0.00N/AN/AN/AN/A7/2/2024 (Estimated)

Latest CPH, CSI, IMCC, TGIFF, and BAMM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
-$0.16-$0.18-$0.02-$0.18$7.59 million$7.86 million
3/14/2024Q4 2023
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
C$0.15C$0.41+C$0.26C$0.41C$7.31 millionC$6.70 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BAMM
BooksAMillion
N/AN/AN/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
N/AN/AN/AN/AN/A
Colossus Minerals Inc. stock logo
CSI
Colossus Minerals
N/AN/AN/AN/AN/A
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
N/AN/AN/AN/AN/A
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BAMM
BooksAMillion
N/AN/AN/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
0.44
9.19
2.67
Colossus Minerals Inc. stock logo
CSI
Colossus Minerals
N/AN/AN/A
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
0.03
0.74
0.44
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BAMM
BooksAMillion
N/A
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
1.03%
Colossus Minerals Inc. stock logo
CSI
Colossus Minerals
N/A
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
7.68%
1933 Industries Inc. stock logo
TGIFF
1933 Industries
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BAMM
BooksAMillion
N/AN/AN/ANot Optionable
Cipher Pharmaceuticals Inc. stock logo
CPH
Cipher Pharmaceuticals
523.99 millionN/ANot Optionable
Colossus Minerals Inc. stock logo
CSI
Colossus Minerals
N/AN/AN/ANot Optionable
IM Cannabis Corp. stock logo
IMCC
IM Cannabis
9513.39 million12.60 millionNot Optionable
1933 Industries Inc. stock logo
TGIFF
1933 Industries
87N/AN/ANot Optionable

CPH, CSI, IMCC, TGIFF, and BAMM Headlines

SourceHeadline
1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary
finance.yahoo.com - April 8 at 7:13 AM
1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary1933 Industries Announces Purchase of 9% Interest of Cultivation and Production Subsidiary
accesswire.com - April 8 at 7:00 AM
1933 Industries Inc.1933 Industries Inc.
barrons.com - April 2 at 3:42 PM
1933 Industries Reports Q2 2024 Financials1933 Industries Reports Q2 2024 Financials
finance.yahoo.com - April 2 at 10:41 AM
1933 Industries Inc.: 1933 Industries Pauses CBD Manufacturing Division1933 Industries Inc.: 1933 Industries Pauses CBD Manufacturing Division
finanznachrichten.de - March 12 at 1:05 PM
1933 Industries Pauses CBD Manufacturing Division1933 Industries Pauses CBD Manufacturing Division
accesswire.com - March 12 at 9:30 AM
1933 Industries Issues Correction1933 Industries Issues Correction
accesswire.com - March 1 at 6:00 PM
1933 Industries Inc.: 1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures1933 Industries Inc.: 1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures
finanznachrichten.de - March 1 at 7:43 AM
1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures1933 Industries Announces the Cancellation of Historical Debentures and the Issuance of New Debentures
accesswire.com - February 29 at 11:00 AM
Hitler takes political control 1933-1934 - CCEAHitler takes political control 1933-1934 - CCEA
bbc.co.uk - February 23 at 2:08 PM
Miller IndustriesMiller Industries
forbes.com - February 16 at 12:45 PM
1933 Industries Inc (TGIF)1933 Industries Inc (TGIF)
investing.com - February 8 at 8:12 PM
CLASSIC CLASSICS: 1933 Ford: V-8 Sedan was popular with the publicCLASSIC CLASSICS: 1933 Ford: V-8 Sedan was popular with the public
decaturdaily.com - January 21 at 12:21 PM
1933 Industries Stock (OTC:TGIFF) Earnings Dates and Earning Calls1933 Industries Stock (OTC:TGIFF) Earnings Dates and Earning Calls
benzinga.com - January 13 at 6:51 PM
1933 Industries reports Q1 results1933 Industries reports Q1 results
msn.com - January 2 at 5:37 PM
1933 Industries Inc.: 1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture1933 Industries Inc.: 1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture
finanznachrichten.de - January 2 at 12:31 PM
1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture1933 Industries Reports First Quarter 2024 Financials and Announces the Issuance of New Debenture
finance.yahoo.com - January 2 at 12:31 PM
1933 Industries reports Q4 results1933 Industries reports Q4 results
msn.com - November 29 at 9:05 AM
1933 Industries Reports Fourth Quarter and 2023 Year-End Financial Results and Posts Record Revenues of $18.3 Million1933 Industries Reports Fourth Quarter and 2023 Year-End Financial Results and Posts Record Revenues of $18.3 Million
finance.yahoo.com - November 29 at 12:41 AM
1933 Industries Stock (OTC:TGIFF) Dividends: History, Yield and Dates1933 Industries Stock (OTC:TGIFF) Dividends: History, Yield and Dates
benzinga.com - November 24 at 12:40 PM
1933 Industries Announces Approval of Debenture Amendments1933 Industries Announces Approval of Debenture Amendments
finance.yahoo.com - November 14 at 6:02 PM
1933 Industries Provides Corporate Update1933 Industries Provides Corporate Update
finance.yahoo.com - October 27 at 9:53 AM
Germany withdraws from League of Nations, disarmament pactGermany withdraws from League of Nations, disarmament pact
upi.com - October 15 at 11:24 PM
TGIFF - 1933 Industries Inc.TGIFF - 1933 Industries Inc.
finance.yahoo.com - September 11 at 6:25 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BooksAMillion

NASDAQ:BAMM
Books-A-Million, Inc. is a book retailer primarily located in the eastern United States and operates both superstores and traditional bookstores. The Company operates through three segments: retail trade, electronic commerce trade, and real estate development and management. The retail trade segment is engaged in the retail sale of books, magazines and general merchandise, including gifts, cards, games, toys, collectibles, music, digital video disc (DVDs), electronic devices and accessories at its retail stores. The electronic commerce trade segment is engaged in the retail sale of books and general merchandise over the Internet. The real estate development and management segment is engaged in developing and leasing commercial retail real estate for purposes of earning rental income.
Cipher Pharmaceuticals logo

Cipher Pharmaceuticals

TSE:CPH
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome. The company's licensed products comprise Absorica, an oral retinoid indicated for the treatment of f severe nodular and/or inflammatory acne, acne conglobate and recalcitrant acne; Lipofen, which is indicated as adjunctive therapy to diet to reduce elevated LDL-C, total-C, triglycerides, and Apo B, and to increase HDL-C, as well as to reduce triglycerides in adult patients; and Conzip, an opioid agonist indicated for the management of moderate to moderately severe chronic pain in adults. Its pipeline products include MOB-015, a topical formulation of terbinafine, which is in phase 3 clinical trial for treatment of onychomycosis; CF-101 (Piclidenoson) that is in phase 3 clinical trial for severe plaque psoriasis and rheumatoid arthritis; and DTR-001, a tattoo removal cream, which is in pre-clinical stage. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Mississauga, Canada.
Colossus Minerals logo

Colossus Minerals

TSE:CSI
Colossus Minerals Inc. (Colossus) is a development-stage mining company. Colossus is focused on its Serra Pelada project into production. The Serra Pelada Project is located in the mineral prolific Carajas region in Para, Brazil, is host to high grade gold and platinum group metals deposit. The Company's three mineral properties in Brazil: the Serra Pelada Project, the Rio Cristalino Property and the Cutia Property. The Serra Pelada Project is the only material property of the Company. The Company's subsidiaries include Colossus Mineracao Ltda., Mineracao Fazenda Monte Belo Ltda., Serra Pelada - Companhia de Desenvolvimento Mineral, and Grifo Geologia e Participacoes Ltda. In January 2012, the Company acquired Cutia Property from Cooperativa Mista do Garimpeiro de Cutia.
IM Cannabis logo

IM Cannabis

NASDAQ:IMCC
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.
1933 Industries logo

1933 Industries

OTCMKTS:TGIFF
1933 Industries Inc., together with its subsidiaries, engages in the cultivation and production of cannabis products in the United States. It operates in three segments: the Medical Segment, the Recreational Segment, and the CBD-Infused Products Segment. The company produces, packages, and markets cannabidiol (CBD)-infused products, including tinctures, vape pens and cartridges, lotions, pain creams, gummies, and capsules under the Canna Hemp and Canna Hemp X brand names. It also offers craft-style cannabis, infused pre-rolls, full spectrum oils, distillates, terpenes, and vaporizer products; and boutique concentrates, such as shatters, crumbles, batters, sugar waxes, diamonds, and cured and live resins under the AMA and Level X brand names. The company offers its products through retail dispensaries and retail outlets, as well as through its e-commerce platform. The company was formerly known as Friday Night Inc. and changed its name to 1933 Industries Inc. in September 2018. 1933 Industries Inc. is headquartered in Vancouver, Canada.